Hello HCV mates,
my name is Artur. I live in Poland. I belive I was HCV infected in hospital because of drip. It happened in 2008. I was dehydrated and physician sent me to hospital. In this time in Poland were cases of sepsis. I was HCV diagnosed in 2009.
Anyway, after the visit in the hospital I was graduating high school and I was preparing to military technical university. One of the recrutation steps are helth tests. Everything was fine, except anti-HCV test. This one was positive. Few weeks before matura exam military physician sent me to the loboratory to get HCV-RNA test. The viral load was 4.05 IU/ml in logarymic scale. After two months, in June, I had another HCV-RNA test and the result was about 40.000 IU/ml. So, the VL rised from 12.000 to 40.000 in really short time. All liver tests were fine. In December my VL was about 200.000 IU/ml. In September I had biopsy and the liver was compleatly fine, no fibrosis.
Hopfully I have been sent to treatement with PegInterferon and RBV. I started this adventure in the end of 2010. Before the threatement my VL was 250.000 IU/ml. In the EOT I have achieved UND HCV-RNA, but I haven't achieved SVR24.
This year I have made fibroscan. The result was F2 (9.1 kPa). The VL was 1.230.000 IU/ml. BTW I don’t drink, smoke, I have never had to do anything with drugs or high risk sexual behaviours. In Poland are avaiable interferon free therapies, but only for people with all other genotypes then GT3. Now I have drugs from India (SoviHep+DaciHep). I have made HCV RNA test after 17 days of treatment and I am undetected (test sensitivity was 21 IU/ml).
On our polish forum we have discussion about treatement lenght. I have decided to be treated for 24 weeks, but some other people say I should have 12 weeks treatement, because of recomendations. In my opinion recomendations are mostly based on economical point of view.
My question is: should I take the medicine for 12 or 24 weeks? Does the treatement length have the influence on SVR?
GT 3a
Contracted: October 2008
Diagnosed: March 2009
First treatement:
VL 250.000 IU/ml
Fibrosis F0
Start: November 2010
Copegus+Pegasys (24 weeks)
EOT: VL UND
SVR24: VL DETECTED
June 2016
Fibrosis F2 (9.1 kPa)
VL 1.230.000 IU/ml
Second treatement:
SoviHep+DaciHep (24 weeks)
Start: 13.08.2016
VL UND: 30.08.2016
VL UND: 27.01.2017 (EOT)
EOT+4 weeks: AlAT 9.8 SVR4
EOT+8 weeks: AlAT 9.7
EOT+12 weeks: AlAT 7.0
EOT+28 weeks: AlAT 7.6 SVR28